PROLOG Study: decreasing cardiovascular disease risk in hypertensive patients by antihypertensive therapy
Aim. To prove the benefits of long-term controlled antihypertensive therapy in patients with mild to moderate arterial hypertension (MiAH, MoAH), comparing to standard treatment in real-world clinical settings. Material and methods. The study was a multi-center, randomized, comparative, prospective...
Main Authors: | S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, N. P. Kutishenko, R. G. Oganov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2005-08-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/980 |
Similar Items
-
Results of the multi-centre study NOCTURN-2 in patients with arterial hypertension, uncontrolled by previous pharmaceutical therapy
by: R. G. Oganov, et al.
Published: (2010-02-01) -
ADVANCE Study: in patients with Type 2 diabetes mellitus, antihypertensive therapy decreases cardiovascular risk inde pendently of baseline blood pressure
by: I. E. Chazova
Published: (2008-04-01) -
SAFARI - RANDOMISED TRIAL ON COMPLEX THERAPY OF ARTERIAL HYPERTENSION AND DISLIPIDEMY. THE MAIN RESULTS
by: S. Y. Martsevich, et al.
Published: (2016-01-01) -
PROLOG study: main results and guidance for further action
by: S. Yu. Martsevich, et al.
Published: (2006-12-01) -
Effektivnoe i bezopasnoe ispol'zovanie perindoprila v doze 8 mg v kachestve startovogo lecheniya bol'nykh arterial'noy gipertoniey v usloviyakh statsionara (po rezul'tatam issledovaniya DOMINANTA)
by: O D Ostroumova, et al.
Published: (2006-06-01)